CBAY
Congressional Trades
| Politician | Stock | Type | Filed | Traded | |
|---|---|---|---|---|---|
Roger MarshallHouse · R · KS |
CBAYCBAY · Stock |
Purchase $1,001 - $15,000 |
Aug 6, 2018 | Jul 19, 2017 | Filing ↗ |
Roger MarshallHouse · R · KS |
CBAYCBAY · Stock |
Sale $1,001 - $15,000 |
Aug 6, 2018 | Jul 19, 2017 | Filing ↗ |
Whale Activity
No 13F positions in CBAY among the institutional filers we track.
KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.
Insider Trading
No open-market insider buys or sells in the last two years.
Recent Insider Transactions
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| McWherter CharlesPresident of R&D | Disposition to issuer | −31.9K | — | — | Mar 22, 2024 | Form 4 ↗ |
| McWherter CharlesPresident of R&D | Disposition to issuer | −15.0K | — | — | Mar 22, 2024 | Form 4 ↗ |
| Shantharam HarishChief Financial Officer | Disposition to issuer | −20.1K | — | — | Mar 22, 2024 | Form 4 ↗ |
| Dickinson KlaraChief Regulatory Officer | Disposition to issuer | −21.0K | — | — | Mar 22, 2024 | Form 4 ↗ |
| Quinlan Paul TGeneral Counsel | Disposition to issuer | −28.4K | — | — | Mar 22, 2024 | Form 4 ↗ |
| Quinlan Paul TGeneral Counsel | Disposition to issuer | −41.8K | — | — | Mar 22, 2024 | Form 4 ↗ |
| Wills Robert JamesDirector | Disposition to issuer | −30.0K | — | — | Mar 22, 2024 | Form 4 ↗ |
| Shah SujalChief Executive Officer · Director | Disposition to issuer | −96.3K | — | — | Mar 22, 2024 | Form 4 ↗ |
| Shah SujalChief Executive Officer · Director | Disposition to issuer | −310.4K | — | — | Mar 22, 2024 | Form 4 ↗ |
| EMSTER KURT VONDirector | Disposition to issuer | −90.0K | — | — | Mar 22, 2024 | Form 4 ↗ |
| Shah SujalChief Executive Officer · Director | Option exercise | +1 | $2.94 | $3 | Mar 13, 2024 | Form 4 ↗ |
| Shah SujalChief Executive Officer · Director | Option exercise | +2,288 | $5.78 | $13K | Mar 13, 2024 | Form 4 ↗ |
| Shah SujalChief Executive Officer · Director | Option exercise | +22.1K | $4.05 | $89K | Mar 13, 2024 | Form 4 ↗ |
| Shah SujalChief Executive Officer · Director | Option exercise | +14.4K | $8.43 | $121K | Mar 13, 2024 | Form 4 ↗ |
| Shah SujalChief Executive Officer · Director | Option exercise | +3,125 | $11.69 | $37K | Mar 13, 2024 | Form 4 ↗ |
| Shah SujalChief Executive Officer · Director | Option exercise | +18.9K | $9.21 | $174K | Mar 13, 2024 | Form 4 ↗ |
| Shah SujalChief Executive Officer · Director | Option exercise | +52.1K | $1.72 | $90K | Mar 13, 2024 | Form 4 ↗ |
| Shah SujalChief Executive Officer · Director | Option exercise | +14.6K | $1.06 | $16K | Mar 13, 2024 | Form 4 ↗ |
| Shah SujalChief Executive Officer · Director | Option exercise | +11.6K | $10.00 | $116K | Mar 13, 2024 | Form 4 ↗ |
| Quinlan Paul TGeneral Counsel | Option exercise | +41.8K | $7.89 | $330K | Mar 13, 2024 | Form 4 ↗ |
Fund Holders
Funds report their holdings by CUSIP, and CBAY could not be matched to one, so no fund holdings are shown.
Activist & Passive Stakes
No 13D/13G beneficial-ownership filings on record.
Corporate Lobbying
No lobbying filings found naming CBAY as the client.
Government Contracts
No federal contract awards found for CBAY.
U.S. Patents
No USPTO patent applications found for CBAY.
Annual Financials
No annual XBRL figures on record for CBAY. KeyVex's fundamentals cover about 130 large companies so far.
Stock Splits
No price history on record for CBAY.
Material Events (8-K)
No 8-K filings on record.
About CBAY
No company profile on record.

